02/23
Headlines

Finance

Morning Alert: Amicus Therapeutics (NASDAQ:FOLD), EMC (NYSE:EMC), Rubicon Technology (NASDAQ:RBCN), Quest Rare Minerals Ltd. (NYSEMKT:QRM), Vera Bradley, Inc. (NASDAQ:VRA)

Jason Knox02 mins

Amicus Therapeutics, Inc. (NASDAQ:FOLD) currently has a Zacks Rank #2 (Buy). Amicus Therapeutics, Inc. (NASDAQ:FOLD) belongs to Healthcare sector. Its weekly performance is 34.38%. On last trading day company shares ended up $7.27. Amicus Therapeutics, Inc. (NASDAQ:FOLD) distance from 50-day simple moving average (SMA50) is 76.12%. EMC (NYSE:EMC) declared a quarterly dividend on Friday, August 1st….

Read More

Fast Moving Stocks: Chesapeake Energy (NYSE:CHK), Symantec (NASDAQ:SYMC), Altair Nanotechnologies, Inc. (NASDAQ:ALTI), Clean Energy Fuels Corp. (NASDAQ:CLNE), Vornado Realty Trust (NYSE:VNO)

Colin Pettis02 mins

On Aug. 21, 2014– Chesapeake Energy Corporation (NYSE:CHK) today announced that Brad Sylvester will join Chesapeake as Vice President – Investor Relations and Communications. Sylvester joins Chesapeake from Southwestern Energy Company. He will report to Chesapeake’s Chief Financial Officer, Nick Dell’Osso. Chesapeake Energy Corporation (NYSE:CHK) belongs to Basic Materials sector. Its net profit margin is…

Read More
Biotech stock market news

Biotech Stocks: Amicus Therapeutics (FOLD) Soars High After Positive Results

Richard Atkins02 mins

Shares of Amicus Therapeutics (FOLD) soared 20.4% after the company announced positive data from its second phase III study (Study 012) on the oral small molecule chaperone migalastat HCl in Fabry patients with amenable mutations. The phase III study is evaluating the use of oral migalastat to standard-of-care enzyme replacement therapies (ERTs) − Sanofi’s (SNY)…

Read More